Navigation Links
American Oriental Bioengineering to Report Second Quarter 2009 Financial Results on August 7, 2009
Date:7/27/2009

NEW YORK, July 27 /PRNewswire-Asia-FirstCall/ -- American Oriental Bioengineering, Inc. (NYSE: AOB), ("the Company" or "AOBO"), a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter ("OTC") products in China, today announced that it plans to release second quarter 2009 financial results on Friday, August 7, 2009, before the market opens.

The Company will hold a conference call at 8:00 am ET on August 7, 2009 to discuss second quarter 2009 results. Listeners may access the call by dialing 1-866-761-0749 or 1-617-614-2707 for international callers, access code: 54060064. A webcast will also be available through AOB's website at http://www.bioaobo.com . A replay of the call will be available through August 14, 2009. Listeners may access the replay by dialing 1-888-286-8010 or 1-617-801-6888 for international callers, access code: 18519426.

About American Oriental Bioengineering, Inc.

American Oriental Bioengineering, Inc. is a pharmaceutical company dedicated to improving health through the development, manufacture and commercialization of a broad range of prescription and over the counter products in China.


'/>"/>
SOURCE American Oriental Bioengineering, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
3. American Stock Exchange Lists The Common Stock Of Neuralstem, Inc.
4. American Oriental Bioengineering Announces Participation in September Investor Conferences
5. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
6. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
7. Tips from the Journals of the American Society for Microbiology
8. Trubion Pharmaceuticals Announces Upcoming Presentations at American College of Rheumatology Annual Scientific Meeting
9. Americas Heartland Launches Third Season Highlighting Contributions of American Farmers and Ranchers
10. American and European Parkinsons Sufferers Find Chinese Stem Cell Treatment Effective, Proving Western Debates Moot
11. AUDIO from Medialink and Pfizer: Hispanic Heritage Month Reminds Us Increasing Numbers of Hispanic-Americans Do Not Have Health Insurance

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Dec. 3 VIA Pharmaceutic...y focused on the development of compounds for the ... today announced that it has completed the last pa...of VIA-2291. ,, The FDG-PET trial enrolled 52 ...US and Canada including Massachusetts General Hosp...
(Date:12/3/2009)... DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Sus...enzhen Beike Biotechnology Co. Ltd.,( http://www.b...Risk Diabetic,Foot Care in New Delhi, India, Novem...esearch and regenerative medicine company. , ...ry Association (IPA), aimed,to help podiatrists an...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Drug Discovery Technologies...ities ,, http://www.reportlinker.com/p0164246...Market-Trends--Opportunities.html ,, Drug disc...f every pharmaceutical company,s business strategy...
(Date:12/2/2009)..., Gabon, December 2 , - "...lem and Heritage" , Coinciding with the I...he,Gabonese Republic is hosting an international c...feguarding biological resources in Africa. The,con...eaders, ministers,scientific experts, private com...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9Libreville International Conference 2-3 June 2010 2
...AL FUELS INDUSTRIES, INC. (Pink Sheets: VGPR) toda... rating for the Company to "Fully Compliant", its ...TC Markets categorizes all securities trading over...nform investors whether an issuer has made adequat... Subsequent to NFI,s recent filing, Pink OTC Mark...
...ing Drives Aggressive Conversion Program , , ST. ...rovider of cell culture materials and services for...aceutical industry and a business segment within S...q: SIAL ), today announced it has completed the ...ntinuous milling production site in Lenexa, Kansas...
...ucralose manufacturer Guangdong Food Industry Inst...p;P) today announced that the U.S. International T...ded the target date of its final decision in the s...tion 337 patent dispute (docket# 337-TA-604) was f...ate & Lyle Corporation (T&L) , ...
Other Biology Technology:Pink OTC Markets Moves Natural Fuels Industries to Top Tier 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 2SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 3SAFC Biosciences(TM) Completes Conversion of Lenexa Media Milling Facility to Animal Component Free 4GDFII/L&P Confirms Target Date Extension Of U.S. ITC Sucralose Ruling 2
(Date:12/3/2009)... , ALBUQUERQUE, N.M. Most scientists believe tha...lls that signal each other to emit toxins. The sig...ny bacteria must be present to start the process. ...ined that the very first stage of staph infection,...t form, occurs in a single cell and that this indi...
(Date:12/3/2009)... , Spanish researchers have measured CO2 levels f...atmosphere) over a sparsely inhabited rural area n...f their kind in the Iberian Peninsula, show that t...05. , Over recent years, physicists and meteorol...ioxide (CO2) levels, and how these have evolved in...
(Date:12/2/2009)... , PHILADELPHIA Less acculturated Latino men h...ose who are more acculturated to U.S. culture, but...itting smoking. Details of these findings are publ...tion , a journal of the American Association for C...ocus on tobacco. , "Acculturation affects smokin...
Breaking Biology News(10 mins):Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 2Stopping MRSA before it becomes dangerous is possible, Sandia/UNM researchers find 3CO2 levels rising in troposphere over rural areas 2Acculturation affects smoking cessation success among Latinos 2Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 1Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 2Anthem Blue Cross and Blue Shield in New Hampshire Gives Boost to Help Small Businesses in the Granite State 51933 3House Health Reform Bill Would Deliver on President Obamas Vision Says Campaign for Americas Future 51930 1New Lewin Report Shows Need for National Medicaid Out of Network Claims Policy 51927 1New Lewin Report Shows Need for National Medicaid Out of Network Claims Policy 51927 2
...d in textbooks, are essential for eukaryotic cells...ts of energy as they use oxygen. However, some euk...mans--such as Entamoeba histolytica, the causal ag...t are too oxygen poor to support this process. Nev...terious organelle, called a mitosome, that is evol...
...ate student may have figured out why rates of exti... marine life during one of the greatest ice ages o...to 290 million years ago, late in the Paleozoic Er... forms that did survive during this era were singu...mperature and sea levels. Those that were not died...
...identifies 34 regions worldwide where 75 percent o... amphibians survive within habitat covering just 2...ent to the combined areas of the five largest U.S....cent of the Earth,s surface, an area equivalent in...alysis shows that an estimated 50 percent of all v...
Other Biology News:Low level of extinction during ice age linked to adaptability 2Biodiversity hotspots identify conservation priorities 2Biodiversity hotspots identify conservation priorities 3Biodiversity hotspots identify conservation priorities 4Biodiversity hotspots identify conservation priorities 5
PRO S-7C Stirrer, Ceramic Top, 115 V from PRO Scientific
Agencourt AMPure 450ml Kit from Agencourt Bioscience
Pyrex brand baffled trypsinizing flask, with beaded neck from Sigma-Aldrich
...lizing 50g of purified RNA samples for RT-PCR and ... all of the advantages and applications you expect... be used for enzymatic applications such as RT-PCR...imised for the stabilization of aqueous RNA sample...
Biology Products: